Number of Antipsychotic Medications Prescribed at Discharge (v2021B2)

Specifications Manual for Joint Commission National Quality Measures (v2021B2)

Posted: 9/29/2021

Print this page

Home » Number of Antipsychotic Medications Prescribed at Discharge

Release Notes:
Data Element
Version 2021B2

Name:

Number of Antipsychotic Medications Prescribed at Discharge

Collected For:

HBIPS-5

Definition:

The number of routinely scheduled antipsychotic medications prescribed to the patient at discharge as documented in the medical record.

Question:

What is the documented number of antipsychotic medications prescribed for the patient at discharge?

Format:

Length:	2 or UTD
Type:	Alphanumeric
Occurs:	1

Allowable Values:

0-99
UTD= Unable to Determine

Notes for Abstraction:

An antipsychotic medication is defined as any of a group of drugs, such as the phenothiazines, butyrophenones or serotonin-dopamine antagonists, which are used to treat psychosis. An antipsychotic medication is also called neuroleptic (refer to Appendix C, Table 10.0- Antipsychotic Medications).

All antipsychotic medications should be counted regardless of the indication for use or the reason documented for prescribing the antipsychotic medication.

If the patient was in an acute-care hospital and had multiple admissions to the psychiatric unit during his or her hospitalization, this information should be abstracted only once at the time of discharge from the hospital.

If the patient is on two forms of the same medication i.e., po and IM, this would be counted as one antipsychotic medication.

Only use Antipsychotic NOS in the following situation:

For new antipsychotics that are not yet listed in Table 10.0 in Appendix C.

It is acceptable to use data derived from pharmacy reports or clinical information systems if they are available and are directly derived from the medical record with a process in place to confirm their accuracy. If this is the case, these may be used in lieu of the suggested data sources listed below.

Suggested Data Sources:

Aftercare discharge plan
Discharge plan
Final discharge summary
Interim discharge summary
Medication reconciliation form
Physician discharge orders
Physician progress notes
Referral form

Additional Notes:

Guidelines for Abstraction:

Inclusion

Exclusion

Refer to Appendix C, Table 10.0- Antipsychotic Medications

PRN antipsychotic medications
Short-acting intramuscular antipsychotic medications (refer to Appendix C, Table 10.1- Short-Acting Intramuscular Antipsychotic Medications)

Specifications Manual for Joint Commission National Quality Measures (v2021B2)
Discharges 10-1-21 through 12-31-21 (4Q21)

LICENSE FOR USE OF CURRENT PROCEDURAL TERMINOLOGY, FOURTH EDITION (“CPT®”)

You, your employees and agents are authorized to use CPT® only as contained in The Joint Commission performance measures solely for your own personal use in directly participating in healthcare programs administered by The Joint Commission. You acknowledge that the American Medical Association (“AMA”) holds all copyright, trademark and other rights in CPT®.

Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT® for resale and/or license, transferring copies of CPT® to any party not bound by this Agreement, creating any modified or derivative work of CPT®, or making any commercial use of CPT®. License to use CPT® for any use not authorized herein must be obtained through the American Medical Association, Intellectual Property Services, AMA Plaza, 330 North Wabash Avenue, Suite 39300, Chicago, Illinois 60611-5885. Applications are available at the American Medical Association Web site, www.ama- assn.org/go/cpt.

U.S. Government Rights This product includes CPT® which is commercial technical data, which was developed exclusively at private expense by the American Medical Association, 330 North Wabash Avenue, Chicago, Illinois 60611. The American Medical Association does not agree to license CPT® to the Federal Government based on the license in FAR 52.227-14 (Data Rights - General) and DFARS 252.227-7015 (Technical Data - Commercial Items) or any other license provision. The American Medical Association reserves all rights to approve any license with any Federal agency.

Disclaimer of Warranties and Liabilities. CPT® is provided “as is” without warranty of any kind, either expressed or implied, including but not limited to the implied warranties of merchantability and fitness for a particular purpose. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT®, and the (AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The responsibility for the content of this product is with The Joint Commission, and no endorsement by the AMA is intended or implied. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this product.

This Agreement will terminate upon notice if you violate its terms. The AMA is a third party beneficiary to this Agreement.

Should the foregoing terms and conditions be acceptable to you, please indicate your agreement and acceptance by clicking below on the button labeled “accept”.